Efficacy and Safety Evaluating Fispemifene in the Treatment of Hypogonadal Men With Erectile Dysfunction Unresponsive to PDE5 Inhibitors

This study has been completed.

Study NCT00415571 Information provided by QuatRx Pharmaceuticals Company

First Received: December 21, 2006 Last Updated: February 2, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	August 2008
Estimated Primary Completion Date:	No date given